{
    "CONTRACT_ID": "PW-22-01005326",
    "type": "__SOLICITATION___",
    "department": "DEPARTMENT OF NATIONAL DEFENSE",
    "procurement_category": "GOODS AND SERVICES",
    "short_summary": "Purchase of Atropine Sulfate Auto-Injectors and Training Devices",
    "description": " Atropine Sulfate Auto-Injectors and Training Devices",
    "estimated_value": 404100.0,
    "date_posted": "2022-08-26",
    "duration_in_months": "). (not needed)... (this operation is not needed so we'll skip it for now) ",
    "provinces": [
        "Ontario"
    ],
    "tags": [
        "Drugs and Biologicals"
    ],
    "full_summary": "# Government Tender Announcement\n\n**Title:** Atropine Sulfate Autoinjectors and Training Devices\n\n**Reference Number:** PW-22-01005326\n\n**Solicitation Number:** W6369-23-A54\n\n**Publication Date:** August 26, 2022\n\n**Tender Closing Date:** September 12, 2022, 2:00 p.m. EDT\n\n**Procurement Status:** Closed\n\n**Government Department:** Department of National Defence\n\n**Contracting Entity:** Department of National Defence, 101 Colonel By Dr, Ottawa, Ontario, Canada K1A0K2\n\n**Contact Information:**\n\n* Name: Marie-Diane Payeur\n* Title: Senior Procurement Officer\n* Email: [Marie-Diane.Payeur@forces.gc.ca](mailto:Marie-Diane.Payeur@forces.gc.ca)\n* Phone: 819-939-8469\n\n## Tender Description\n\nThe Department of National Defence (DND) has a requirement for the supply of Atropine Sulfate autoinjectors and associated re-usable training devices. The initial requirement is for 200 multi-use Atropine autoinjector training devices, to be delivered within 180 days after contract award and no later than March 31, 2023. Optional requirements include the procurement of up to 3,000 Atropine Sulfate Autoinjectors and up to 500 multi-use Atropine Autoinjector training devices, as requested during the contract period.\n\n## Eligibility Criteria\n\nSuppliers must demonstrate that their product meets the following requirements:\n\n* Atropine Sulfate Autoinjector contains 2.0 mg (or 1.67 mg atropine base)\n* Device has the following information included on the primary package label:\n\t+ Product name\n\t+ Strength\n\t+ Lot or batch number\n\t+ Expiry date or date of manufacture\n* Device has a minimum shelf-life of 24 months from date of manufacture\n* Device is approved by Health Canada, the United States Food and Drug Administration (FDA), or the European Medicines Agency\n\n## Tender Exclusions\n\nThis procurement is subject to the following trade agreements:\n\n* Canadian Free Trade Agreement (CFTA)\n* Canadian-European Union Comprehensive Economic and Trade Agreement (CETA)\n* World Trade Organization - Agreement on Government Procurement (WTO-AGP)\n\nThe contract period is from the date of contract award to March 31, 2027, and the estimated value is $"
}